Centre for Nuclear Medicine
On 14thJune 2024, Dr. Sudeep Gupta, Director – TATA Memorial Centre, inaugurated ‘Nuclear Medical Centre’ for cancer diagnosis and treatment in a grand ceremony at B. K. L. Walwalakar Hospital and Medical College; Srishetra – Dervan. On this occasion, Ms. Riddhi Bhatia, Mr. Yogesh Karmarkar, representatives of Kotak Mahindra Bank, who has given huge financial support to this centre; Ms. Chitra and Ms. Hemadri Buzruk of Rama- Purushottam Trust, Officers of Nana Palkar Trust, Dr. Shripad Banavali, Director (Academic), Tata Memorial Centre, Mumbai; Executive Trustee of Vitthalrao Joshi Charities Trust Shri. Vikasrao Walawalkar and Chief Trustee, Shri. Ashokrao Joshi, Medical Director of Dervan Hospital Dr. Suvarna Patil, Dean of, B.K.L. Walawalkar.
Medical College Dr. Mansingh Ghatage, Dr. Rita Mulherkar, and much more dignitaries, faculty, staff, students and locals were present. Chief Guest Dr. Sudeep Gupta and his wife Dr. Sumedha Gupta, including the guests of honor, had reached Dervan the evening before. All of them were given a tour of the medical college, and in the college’s conference hall, Dr. Suvarna Patil gave an elaborate presentation to the guests about the philanthropic work that the Trust undertakes in a variety of fields. Each guest took an interested look around the hospital. The “Nuclear Medicine Centre,” which is 6500 square feet in size and features PET and SPECT facilities in addition to high and low doses of nuclide therapy, is being inaugurated today; in a recently built multi-storey structure. Every structure, including walls, floors, and ceilings, etc. are 230 mm, as advised by the AERB, made of substantial reinforced concrete. 6.10 X 7.5 m for SPECT and PET imaging. Size rooms have been built with a separate electrical room, radio pharmacy, dose administration room, waiting area, safe radioactive waste storage system, and separate room for radioactive material storage. Attached labs are also included. Here, the heart’s muscle strength is also assessed through a “stress test.” A separate room has been set up for patients receiving high dose therapy. According to AERB standards, two 6000-liter tanks are constructed for contaminated miles. The people of Konkan will be benefitted from PET-CT ScanF-18, FDGF-18, PSMAF-18, Cardiac Viability, and SPECT Scan for Renal, Cardiac, Liver, Bone, Thyroid, GE Reflux, Lung Perfusion scan, lodine therapy for thyroid disorders etc.
MBBS Students Visit to Centre for Nuclear Medicine
List of Test
| Sr. No. | Test name | OPD/ IPD | Indication | |
|---|---|---|---|---|
| 1 | F-18 FDG PET CT (CECT) | OPD | Benign & Malignant tumors | |
| 2 | F-18 FDG PET CT ( NCCT) | OPD | Benign & Malignant tumors with elevated serum creatinine, sarcoma, lymphoma | |
| 3 | Cardiac FDG PET CT: | OPD | viability | |
| 4 | F-18 DOPA PET CT | OPD | Brain tumors, epilespy ,etc | |
| 5 | PSMA PET CT | OPD | Ca prostate | |
| 6 | SSR PET CT | OPD | NET | |
| 7 | Myocardial perfusion imaging (MPI)-MIBI scan | OPD | Viability | |
| Rest | OPD | |||
| Stress | ||||
| 8 | Pertechnetate Thyroid scintigraphy | OPD | Graves disease & Thyroiditis | |
| 9 | Bone scintigraphy | OPD | Benign & Malignancy, cellulitis, osteomylittis | |
| 10 | Three Phase bone scan | |||
| 11 | Parathyroid scintigraphy | OPD | Adenoma, Hyperplasia | |
| 12 | DTPA scan | OPD | Obstructive Uropathy | |
| 13 | DMSA scan | OPD | Infections, Absolute Function | |
| 14 | EC scan | OPD | MRD, Renal Failure | |
| 15 | Lung Perfusion | OPD | Pulmonary embolism | |
| 16 | Radioiodine scan | OPD | Post Thyroidectomy | |
| 17 | m-IBG Scan | OPD | Pheochromocytoma and neuroblastomas. | |
| Therapy Procedures | ||||
| 18 | Radioiodine therapy (Low dose 10 mci) | OPD | Grave’s disease | |
| (Low dose 15 mci) | OPD | Grave’s disease | ||
| 19 | Radioiodine therapy (High Dose) | 50 mCi | Indoor stay | Papillary Carcinoma |
| 100 mCi | Indoor stay | Papillary Carcinoma with nodal mets | ||
| 150 mCi | Indoor stay | Papillary Carcinoma with lung mets Follicular carcinoma | ||
| 200 mCi | Indoor stay | |||
| 250 mCi | Indoor stay | |||
| 20 | PRRT(Lu-177) DOTA TATE therapy | 100 mCi | Day care | CRPC |
| 200 mCi | Day care | – | ||
| PRRT(Lu-177) PSMA therapy | 100 mCi | Day care | Ca prostate | |
| 200 mCi | Day care | – | ||
| 21 | m-IBG therapy | 100 mCi | Indoor stay | pheochromocytoma and neuroblastomas. |












